North America Diabetes Devices Market valuation $28.50 billion by 2033 - Exclusive Report by DatamIntelligence

"The North America Diabetes Devices market size reached US$ 13.76 Billion in 2024 and is expected to reach US$ 28.50 Billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/north-america-diabetes-devices-market?sp

United States: Recent Industry Developments

✅ In November 2025, Walmart Inc. began offering Abbott Laboratories' over-the-counter Lingo continuous glucose monitor (CGM) in over 3,500 stores and online, giving consumers direct access to advanced metabolic health monitoring without prescriptions. The move expands patient access and awareness of diabetes management tools. It reinforces the trend toward consumer-focused diabetes devices in North America.

✅ In October 2025, Dexcom, Inc. announced the layoff of approximately 319 employees in California while shifting manufacturing operations to Arizona as part of strategic realignment and cost-optimization in the evolving U.S. diabetes device market. The decision supports operational efficiency and long-term growth in sensor-based glucose monitoring. It demonstrates the dynamic restructuring happening in the North American diabetes sector.

✅ In September 2025, Medtronic plc received U.S. FDA clearance for its MiniMed 780G automated insulin delivery system for insulin-dependent type 2 diabetes patients, interoperable with Abbott Diabetes Care sensors. The approval expands closed-loop insulin pump therapy to new patient segments. It highlights the integration trend of CGMs and pumps in North American diabetes care.

✅ In August 2025, market reports indicated that North America continues to lead the global diabetes device market, driven by rising diabetes prevalence, increasing adoption of digital health tools, and enhanced connectivity of CGMs, pumps, and smart monitoring systems. The region's dominance reflects innovation and consumer demand for integrated diabetes management solutions. It underscores the central role of North America in advancing diabetes care technologies.

North America Diabetes Devices Market: Drivers

The diabetes devices market in North America is experiencing significant growth due to rising prevalence of diabetes, increasing awareness about disease management, and advancements in healthcare technology. Devices such as continuous glucose monitors, insulin pumps, and smart pens are enabling patients to monitor and manage blood glucose levels more effectively, improving overall health outcomes. Growing adoption of connected and wearable devices for remote monitoring and real-time data analytics is further driving market expansion. Increasing emphasis on personalized healthcare, preventive care, and patient self-management is encouraging both patients and healthcare providers to invest in advanced diabetes management tools. Additionally, government initiatives, insurance coverage, and reimbursement policies are supporting broader adoption of diabetes devices across the region.

Technological innovations in sensor accuracy, non-invasive monitoring, and integration with mobile apps and cloud platforms are enhancing usability and patient compliance. Collaborations between device manufacturers, digital health companies, and healthcare providers are accelerating product development and clinical validation. Rising awareness campaigns about diabetes management, coupled with training programs for healthcare professionals, are promoting adoption and proper usage. Expansion of retail, pharmacy, and online distribution channels is improving accessibility for patients. With continuous innovation, growing diabetes prevalence, and increasing focus on personalized care, the North America diabetes devices market is poised for sustained growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/north-america-diabetes-devices-market?sp

North America Diabetes Devices Market: Major Players

Johnson & Johnson Services, Inc., Abbott, Dexcom Inc, Tandem Diabetes Care, Inc., LifeScan IP Holdings, LLC., Medtronic, Insulet Corporation, F. Hoffmann-La Roche AG, ACON Laboratories, Inc., Novo Nordisk A/S., among others.

Segment Covered in the North America Diabetes Devices Market:

By Device Type
The North America Diabetes Devices Market is segmented into Blood Glucose Monitoring (BGM) Devices, Management Devices, and Others. BGM devices dominate the market due to their essential role in daily glucose tracking. Management devices such as insulin pumps are gaining popularity for enhancing patient comfort and precision in diabetes control.

By Distribution Channel
Distribution channels include Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, and Others. Retail and hospital pharmacies lead the market, offering easy access to diagnostic and management devices. Online pharmacies are rapidly expanding with rising e-health adoption and convenience-based purchasing.

By Country
The market covers the U.S., Canada, Mexico, and Rest of North America. The U.S. holds the largest share, supported by advanced healthcare infrastructure and strong insurance coverage. Canada and Mexico are experiencing steady growth through government initiatives and increasing diabetes awareness
programs.

Regional Analysis

United States
The United States dominates the North America Diabetes Devices Market with approximately 78% share, driven by high diabetes prevalence, advanced healthcare systems, and widespread adoption of continuous glucose monitoring (CGM) technologies. Strong reimbursement policies and innovation from leading players like Abbott and Medtronic further enhance market growth.

Canada
Canada holds around 12% of the regional market, supported by government-led health programs and increasing awareness about diabetes management. The growing use of digital health platforms and telemedicine services is encouraging patients to adopt connected glucose monitoring devices.

Mexico
Mexico accounts for nearly 7% of the market, with demand rising due to a growing diabetic population and expanding access to affordable monitoring solutions. Public health campaigns and collaborations between global and local manufacturers are fostering wider device availability.

Purchase this report before year-end and unlock an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=north-america-diabetes-devices-market
(Purchase 2 or more Repots and get 50% Discount)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.